Rothschild & Co Asset Management US’s AtriCure ATRC Stock Holding History

Rothschild & Co Asset Management US’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.75M	Sell	84,504 -775	-0.9%	-$32.4K	0.06%	197
2022 Q3	$3.33M	Buy	85,279 +2,598	+3%	+$119K	0.06%	212
2022 Q2	$3.38M	Sell	82,681 -2,722	-3%	-$129K	0.05%	216
2022 Q1	$5.61M	Sell	85,403 -31,634	-27%	-$2.05M	0.07%	193
2021 Q4	$8.14M	Sell	117,037 -7,758	-6%	-$564K	0.1%	192
2021 Q3	$8.68M	Sell	124,795 -19,664	-14%	-$1.51M	0.11%	189
2021 Q2	$11.5M	Sell	144,459 -4,999	-3%	-$363K	0.14%	174
2021 Q1	$9.79M	Sell	149,458 -19,373	-11%	-$1.19M	0.12%	194
2020 Q4	$9.4M	Buy	168,831 +67,780	+67%	+$2.93M	0.12%	193
2020 Q3	$4.03M	Sell	101,051 -13,829	-12%	-$586K	0.07%	245
2020 Q2	$5.16M	Buy	+114,880	New	+$5M	0.08%	255

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Rothschild & Co Asset Management US's ATRC Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its AtriCure (ATRC) stake by 0.91% in Q4 2022, selling an estimated $32.4K and leaving 84,504 shares worth $3.75M. The position accounts for 0.06% of the portfolio, ranked #197.

Rothschild & Co Asset Management US first reported a position in ATRC in Q2 2020 and has held it in 11 quarters since. The position peaked at $11.5M in Q2 2021. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

Rothschild & Co Asset Management US held 84,504 shares of AtriCure worth $3.75M as of Q4 2022.
Rothschild & Co Asset Management US sold 775 AtriCure shares in Q4 2022, an estimated $32.4K.
AtriCure made up 0.06% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #197 holding.
Rothschild & Co Asset Management US first reported a position in AtriCure in Q2 2020 and has held it in 11 quarters since.
Rothschild & Co Asset Management US's AtriCure position peaked at $11.5M in Q2 2021.
211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.